Tags |
|
|
Links |
|
|
Main Subject - Innovation Management - Good Leadership
Creativity can be defined as problem identification and idea generation whilst innovation can be defined a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
s idea selection, development and commercialisation.
There are other useful definitions in this field, fo
There are other useful definitions in this field, fo
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
example, creativity can be defined as consisting of a number of ideas, a number of diverse ideas and a nu
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ber of novel ideas.
There are distinct processes that enhance problem identification and idea generation
There are distinct processes that enhance problem identification and idea generation
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and, similarly, distinct processes that enhance idea selection, development and commercialisation. Whilst
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
here is no sure fire route to commercial success, these processes improve the probability that good ideas
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ill be generated and selected and that investment in developing and commercialising those ideas will not b
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e wasted.
Good Leadership
All of the above stages require good leaders to facilitate, manage, g
Good Leadership
All of the above stages require good leaders to facilitate, manage, g
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ide and optimise output. There are certain characteristics of leaders that maximise output:
a) Good leade
a) Good leade
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s are adept at switching between low and high status – high for keeping control and low to ensure others d
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
NOT shut down.
b) Good leaders are aware that idea generation is a cognitive process and encourage expre
b) Good leaders are aware that idea generation is a cognitive process and encourage expre
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ssion of that cognitive activity.
c) Good leaders tend to spend significant amounts of time on problem id
c) Good leaders tend to spend significant amounts of time on problem id
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ntification.
d) Good leaders allow participants periods of incubation to arrive at richer solutions.
e)
d) Good leaders allow participants periods of incubation to arrive at richer solutions.
e)
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ood leaders take advantage of time pressure to force output.
f) Good leaders allow direct access to decis
f) Good leaders allow direct access to decis
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ion makers, knowing that ideas are diluted and feedback decreased when passing through layers.
These and
These and
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ther topics are covered in depth in the MBA dissertation on Managing Creativity & Innovation, which can be
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
purchased (along with a Creativity and Innovation DIY Audit, Good Idea Generator Software and Power Point
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
Presentation) from http://www.managing-creativity.com/
You can also receive a regular, free newsletter by
You can also receive a regular, free newsletter by
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
entering your email address at this site.
Kal Bishop, MBA
**********************************
You are fr
Kal Bishop, MBA
**********************************
You are fr
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e to reproduce this article as long as no changes are made and the author's name and site URL are retained
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24197/mainsubjects-Innovation-Management--Good-Leadership.html">Innovation Management - Good Leadership</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24197/mainsubjects-Innovation-Management--Good-Leadership.html]Innovation Management - Good Leadership[/url]
Related Articles:
Career Change - Making the Big Leap
Bookmark it:
|